A medical distribution company supplying human tissue allografts and point-of-care systems to licensed healthcare providers — with complete documentation on every lot.
Stem Biologics LLC is a medical distribution company serving licensed healthcare providers. We source human tissue allografts and point-of-care systems, verify their regulatory status and documentation, and deliver them under validated handling conditions. We do not manufacture products, and we do not direct clinical care.
Amniotic, placental, and other human tissue allografts sourced from FDA-registered establishments. Donor eligibility documentation and lot-specific certificates of analysis supplied with every shipment.
FDA-cleared platelet-rich plasma and autologous processing systems for point-of-care use, supplied with device documentation, instructions for use, and in-service training.
Written regulatory classification, establishment registration, donor screening and testing records, and certificates of analysis — assembled for your file before first use.
Validated shipping, storage specifications, and receiving protocols so product remains within its labeled conditions from processor to point of care.
Documentation, coding, and workflow guidance reflecting current CMS payment policy, including the 2026 changes to skin substitute reimbursement.
Training and consultation on product handling, storage, regulatory classification, and use consistent with each product's labeling.
Stem Biologics LLC is a distributor. Products are supplied to licensed healthcare professionals for use consistent with each product's labeling and applicable regulatory classification. Human tissue allografts distributed as 361 HCT/Ps under 21 CFR Part 1271 are not FDA-approved or licensed products, and are intended for homologous use only. Nothing on this site is a representation that any product diagnoses, treats, cures, or prevents any disease, or an offer to sell any product for a use outside its labeling. Regulatory classification for any product is available in writing on request.
Hemostasis, inflammation, proliferation, remodeling. A plain-language walk through the four overlapping phases of wound healing — and a look at why some wounds stall along the way.
Consent, screening, recovery, processing, traceability. The regulated chain of custody most people never see — and why every step generates a record.
Autologous, allograft, PRP, HCT/P, minimal manipulation — and the difference between “FDA registered,” “cleared,” and “approved.”
Whether you're a physician, researcher, or distributor — we'd love to hear from you.